OpenAlex
PricingAboutJobs
Log inGet started
Work

Low‐dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: British Journal of Haematology
DOI: 10.1111/j.1365-2141.2005.05521.x
Authors: Charalampia Kyriakou, Kirsty Thomson, Shirley D'Sa, Angela Flory, Judith Hanslip, Anthony H. Goldstone, Kwee L. Yong
Institutions: University College Hospital, University College London Hospitals NHS Foundation Trust, West Hertfordshire Hospitals NHS Trust
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed multiple myeloma, refractory multiple myeloma, thalidomide, cyclophosphamide, dexamethasone, triple therapy, maintenance therapy, high-dose therapy, autologous stem cell transplantation, event-free survival, treatment toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2058115046
FWCI: 7.391
Cites: 46
Cited by: 117
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security